U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
183481183481Evaluation of Eflornithine on Facial and Forearm SkinCompletedNo Results AvailableHirsutismDrug: Eflornithine hydrochloridehttps://ClinicalTrials.gov/show/NCT00152048
183482183482Safety of SPD465 in Treating Adults With ADHD.CompletedNo Results AvailableAttention Deficit Disorder With Hyperactivity.Drug: Neutral salts of dextroamphetamine sulfate, USP, amphetamine sulfate, USP, d-amphetamine saccharate, d, l-amphetamine aspartate monohydrate.https://ClinicalTrials.gov/show/NCT00152035
183483183483Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD.CompletedNo Results AvailableAttention Deficit Disorder With Hyperactivity.Drug: Neutral salts of dextroamphetamine sulfate, USP, amphetamine sulphate, USP, d-amphetamine saccharate, d, l-amphetamine aspartate monohydrate.https://ClinicalTrials.gov/show/NCT00152022
183484183484Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17CompletedHas ResultsAttention Deficit Disorder With HyperactivityDrug: SPD503 (Guanfacine hydrochloride) (2 mg)|Drug: SPD503 (3 mg)|Drug: SPD503 (4 mg)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00152009
183485183485Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedHas ResultsAttention Deficit Disorder With HyperactivityDrug: Methylphenidate + SPD503 (Guanfacine hydrochloride)|Drug: Amphetamine + SPD503https://ClinicalTrials.gov/show/NCT00151996
183486183486Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate TherapyCompletedNo Results AvailableAttention Deficit Disorder With HyperactivityDrug: Methylphenidate Transdermal Systemhttps://ClinicalTrials.gov/show/NCT00151983
183487183487Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHDCompletedNo Results AvailableAttention Deficit Disorder With HyperactivityDrug: Methylphenidate Transdermal System|Drug: Placebo|Drug: Concertahttps://ClinicalTrials.gov/show/NCT00151970
183488183488Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS TrialsCompletedNo Results AvailableAttention Deficit Disorder With Hyperactivity.Drug: Methylphenidate Transdermal Systemhttps://ClinicalTrials.gov/show/NCT00151957
183489183489Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.CompletedNo Results AvailableColitis, UlcerativeDrug: SPD476 (mesalazine)https://ClinicalTrials.gov/show/NCT00151944
183490183490Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving DialysisCompletedNo Results AvailableKidney Failure, ChronicDrug: Lanthanum carbonatehttps://ClinicalTrials.gov/show/NCT00151931
183491183491Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal DiseaseCompletedNo Results AvailableKidney Failure, ChronicDrug: Lanthanum carbonatehttps://ClinicalTrials.gov/show/NCT00151918
183492183492The Use of an Inhaled Salt Solution to Treat Viral Lung Infections in Infants.CompletedNo Results AvailableBronchiolitisDrug: 3 % hypertonic salinehttps://ClinicalTrials.gov/show/NCT00151905
183493183493Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative ColitisCompletedHas ResultsColitis, UlcerativeDrug: SPD476|Drug: Asacolhttps://ClinicalTrials.gov/show/NCT00151892
183494183494Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial SeizuresCompletedNo Results AvailableEpilepsies, PartialDrug: SPM 927https://ClinicalTrials.gov/show/NCT00151879
183495183495Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus PlasmaCompletedNo Results AvailableHemato-Oncologic Patients|Myelosuppression|ThrombocytopeniaProcedure: platelet transfusionhttps://ClinicalTrials.gov/show/NCT00151866
183496183496Study Use of PPSB-SD and VP-VI in Patients With Anticoagulant Therapy and Undergoing Acute CPB SurgeryCompletedNo Results AvailableCPB|Oral Anticoagulant TherapyDrug: PPSB-SDhttps://ClinicalTrials.gov/show/NCT00151853
183497183497Efficacy and Safety of IVIG-L in ITP PatientsCompletedNo Results AvailablePurpura, Thrombocytopenic, IdiopathicDrug: IVIG-Lhttps://ClinicalTrials.gov/show/NCT00151840
183498183498Olmesartan Medoxomil in Hypertension and Renal ImpairmentCompletedNo Results AvailableEssential Hypertension|Renal ImpairmentDrug: Olmesartan medoxomil|Drug: Losartan|Drug: Furosemide oral tabletshttps://ClinicalTrials.gov/show/NCT00151827
183499183499Olmesartan Pediatric Pharmacokinetic (PK) StudyCompletedHas ResultsHypertensionDrug: Olmesartan medoxomilhttps://ClinicalTrials.gov/show/NCT00151814
183500183500Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS PatientsRecruitingNo Results AvailableMultiple SclerosisDrug: estroprogestins|Drug: interferon-beta 1ahttps://ClinicalTrials.gov/show/NCT00151801
183501183501Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE.TerminatedNo Results AvailableAtherosclerosis|Heterozygous Familial HypercholesterolemiaDrug: Pactimibe sulfatehttps://ClinicalTrials.gov/show/NCT00151788
183502183502Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood PressureCompletedHas ResultsHypertensionDrug: olmesartan medoxomil|Drug: placebo|Drug: olmesartan medoxomilhttps://ClinicalTrials.gov/show/NCT00151775
183503183503Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 DiabetesCompletedNo Results AvailableType 2 DiabetesDrug: Colesevelam hydrochloridehttps://ClinicalTrials.gov/show/NCT00151762
183504183504WelChol® and Insulin in Treating Patients With Type 2 DiabetesCompletedNo Results AvailableType 2 DiabetesDrug: Colesevelam hydrochloridehttps://ClinicalTrials.gov/show/NCT00151749
183505183505Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)TerminatedNo Results AvailableChronic Lymphocytic LeukemiaDrug: Chlorambucil|Drug: R-etodolac + chlorambucilhttps://ClinicalTrials.gov/show/NCT00151736
183506183506Does Radioiodine Treatment Prevent Atrial Fibrillation and Bone Loss in Endogenous Subclinical Hyperthyroidism?RecruitingNo Results AvailableHyperthyroidismProcedure: treatment with 131Ihttps://ClinicalTrials.gov/show/NCT00151723
183507183507Effects of Pioglitazone in Congenital Adrenal HyperplasiaCompletedNo Results AvailableCongenital Adrenal HyperplasiaDrug: Pioglitazonehttps://ClinicalTrials.gov/show/NCT00151710
183508183508LANN-study: Lantus, Amaryl, Novorapid, Novomix StudyCompletedNo Results AvailableDiabetes Mellitus Type IIDrug: Novomix 30|Drug: Novorapid and Amaryl|Drug: Lantushttps://ClinicalTrials.gov/show/NCT00151697
183509183509Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese MenCompletedNo Results AvailableObesity|HyperinsulinismDrug: Diazoxidehttps://ClinicalTrials.gov/show/NCT00151684
183510183510Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver CancerTerminatedNo Results AvailableLiver Cancer|Hepatocellular Carcinoma|Cirrhosis|Liver FibrosisDrug: Oral Impact®|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00151671

* Görseller ve İçerik tekif hakkına sahip olabilir